Judith Margarete Gottwein

Judith Margarete Gottwein

Lektor


  1. 2013
  2. Udgivet

    Efficient cell culture system for hepatitis C virus genotype 5A: Patent #: 8,618,275

    Jensen, T. B., Gottwein, Judith Margarete, Scheel, T. K. H., Eugen-Olsen, J. & Bukh, Jens, 31 dec. 2013, IPC nr. C07H 21/00 (20060101); C12N 7/00 (20060101); A61K 39/295 (20060101); A61K 39/12 (20060101); A61K 39/29 (20060101), Patentnr. WO2008/141651, 27 nov. 2008, Prioritetsdato 19 maj 2008, Prioritetsnr. PCT/DK2008/050113

    Publikation: Patent

  3. Udgivet

    Adapted J6/JFH1-based Hepatitis C virus recombinants with genotype-specific NS4A show similar efficacies against lead protease inhibitors, alpha interferon, and a putative NS4A inhibitor

    Gottwein, Judith Margarete, Jensen, S. B., Serre, S. B. N., Ghanem, L., Scheel, Troels Kasper Høyer, Jensen, T. B., Krarup, H., Uzcategui, N., Mikkelsen, L. S. & Bukh, Jens, dec. 2013, I: Antimicrobial Agents and Chemotherapy. 57, 12, s. 6034-49 16 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  4. Udgivet

    Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance

    Serre, S. B. N., Krarup, H. B., Bukh, Jens & Gottwein, Judith Margarete, dec. 2013, I: Journal of Virology. 87, 23, s. 12776-93 18 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  5. Udgivet

    Efficient cell culture system for hepatitis C virus genotype 6A: Patent #: 8,569,472

    Gottwein, Judith Margarete, Scheel, T. K. H., Jensen, T. B. & Bukh, Jens, 29 okt. 2013, IPC nr. C07H 21/00 (20060101); C12N 7/00 (20060101); A61K 39/295 (20060101); A61K 39/12 (20060101); A61K 39/29 (20060101), Patentnr. WO2009/080052, 2 jul. 2009, Prioritetsdato 19 dec. 2008, Prioritetsnr. PCT/DK2008/050332

    Publikation: Patent

  6. Udgivet

    Efficient cell culture system for hepatitis C virus genotype 1a and 1b: Patent #: 8,563,706

    Scheel, T. K. H., Gottwein, Judith Margarete, Prentø, Jannick, Jensen, T. B. & Bukh, Jens, 22 okt. 2013, IPC nr. C07H 21/00 (20060101); A61K 39/29 (20060101); A61K 39/12 (20060101); A61K 39/295 (20060101); C12N 7/00 (20060101), Patentnr. WO2009/080053, 2 jul. 2009, Prioritetsdato 19 dec. 2008, Prioritetsnr. PCT/DK2008/050333

    Publikation: Patent

  7. Udgivet

    Analysis of hepatitis C virus core/NS5A protein co-localization using novel cell culture systems expressing core-NS2 and NS5A of genotypes 1-7

    Galli, A., Scheel, Troels Kasper Høyer, Prentø, Jannick, Mikkelsen, L. S., Gottwein, Judith Margarete & Bukh, Jens, okt. 2013, I: The Journal of general virology. 94, Pt 10, s. 2221-35 15 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  8. Udgivet

    Viral hepatitis: Cell-culture-derived HCV--a promising vaccine antigen

    Gottwein, Judith Margarete & Bukh, Jens, sep. 2013, I: Nature Reviews. Gastroenterology & Hepatology. 10, 9, s. 508-9 2 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  9. Udgivet

    Efficient cell culture system for hepatitis C virus genotype 7a: Patent #: 8,506,969

    Gottwein, Judith Margarete, Scheel, T. K. H., Jensen, T. B. & Bukh, Jens, 13 aug. 2013, IPC nr. A61K 39/12 (20060101); A61K 39/29 (20060101); C12Q 1/70 (20060101); C12N 15/00 (20060101); C12N 5/071 (20100101); C12N 1/20 (20060101), Patentnr. WO2010/017819, 18 feb. 2010, Prioritetsdato 31 jul. 2009, Prioritetsnr. PCT/DK2009/050193

    Publikation: Patent

  10. Udgivet

    Adaptive mutations allow establishment of JFH1-based cell culture systems for hepatitis C virus genotype 4A: Patent #: 8,454,974

    Scheel, T. K. H., Gottwein, Judith Margarete, Eugen-Olsen, J. & Bukh, Jens, 4 jun. 2013, IPC nr. A61K 39/29 (20060101); C07H 21/00 (20060101); C12N 15/06 (20060101); C12N 7/02 (20060101); C12Q 1/02 (20060101), Patentnr. WO2008/125119, 23 okt. 2008, Prioritetsdato 11 apr. 2008, Prioritetsnr. PCT/DK2008/050085

    Publikation: Patent

  11. Udgivet

    Combination treatment with hepatitis C virus protease and NS5A inhibitors is effective against recombinant genotype 1a, 2a, and 3a viruses

    Gottwein, Judith Margarete, Jensen, S. B., Li, Y., Ghanem, L., Scheel, Troels Kasper Høyer, Serre, S. B. N., Mikkelsen, L. & Bukh, Jens, mar. 2013, I: Antimicrobial Agents and Chemotherapy. 57, 3, s. 1291-303 13 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Forrige 1 2 Næste

ID: 40928930